A Randomized, Placebo-Controlled Clinical Trial of Tacrolimus Ophthalmic Suspension 0.1% in Severe Allergic Conjunctivitis

Author:

Ohashi Yuichi1,Ebihara Nobuyuki2,Fujishima Hiroshi3,Fukushima Atsuki4,Kumagai Naoki5,Nakagawa Yayoi6,Namba Kenichi7,Okamoto Shigeki8,Shoji Jun9,Takamura Etsuko10,Hayashi Kunihiko11

Affiliation:

1. Department of Ophthalmology, University of Ehime School of Medicine, Shizukawa, Toon City Ehime, Japan.

2. Department of Ophthalmology, Juntendo University school of Medicine, Tokyo, Japan.

3. Department of Ophthalmology, International University of Health and Welfare, Mita Hospital, Tokyo, Japan.

4. Department of Ophthalmology, Kochi Medical School, Kochi, Japan.

5. Kumagai Eye Clinic, Yamaguchi, Japan.

6. Nakagawa Eye Clinic, Osaka, Japan.

7. Department of Ophthalmology and Visual Science, Hokkaido University Graduate School of Medicine, Hokkaido, Japan.

8. Okamoto Eye Clinic, Ehime, Japan.

9. Department of Ophthalmology, Division of Visual Sciences, Nihon University School of Medicine, Tokyo, Japan.

10. Department of Ophthalmology, Tokyo Women’s Medical University, School of Medicine, Tokyo, Japan.

11. School of Health Sciences, Gunma University, Gunma, Japan.

Publisher

Mary Ann Liebert Inc

Subject

Pharmacology (medical),Pharmacology,Ophthalmology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3